Full Measure: November 26, 2023 – The Clot Factor

VIDEO AND DESCRIPTION IMPORTED FROM YOUTUBE

Today we begin with a critically important investigation that stands to impact millions. Only now are scientists starting to unravel some of the most confounding mysteries surrounding the many illnesses that can linger similarly after both Covid and Covid vaccines or suddenly sometimes emerge months or years later. Many physicians are left in the dark, without effective treatment guidance from public health experts. But we found one doctor-turned-medical-detective whose findings are viewed as so groundbreaking, his help is sought-after from doctors and patients across the U.S. and beyond.

———
Full Measure is a weekly Sunday news program focusing on investigative, original and accountability reporting. The host is Sharyl Attkisson, five-time Emmy Award winner and recipient of the Edward R. Murrow award for investigative reporting. She is backed by a team of award winning journalists.

Each week, we have a cover story that explores untouchable topics in a fearless way including: immigration, terrorism, government waste, national security and whistleblower reports on government and corporate abuse and misdeeds.

Full Measure is broadcast to 43 million households in 79 markets on 162 Sinclair Broadcast Group stations, including ABC, CBS, NBC, FOX, CW, MyTV, Univision and Telemundo affiliates. It also streams live Sunday mornings at 9:30 a.m. ET.

Read more about us at: http://fullmeasure.news/about
Find out where to watch us at: http://fullmeasure.news/about
Like us on Facebook: https://www.facebook.com/FullMeasureNews
Follow us on Twitter: https://twitter.com/FullMeasureNews

This video and all Sinclair Broadcast Group content archives of local news and sports coverage are available for your use. For more information contact us at contentsales@sbgtv.com

Original source: https://www.youtube.com/watch?v=tH825m6vq8A

0 0 votes
Article Rating

Follow Full Measure News on:

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments